Meyka Pro banner
Mobia Medical, Inc. Common Stock

Mobia Medical, Inc. Common Stock Fundamental Analysis

MOBINASDAQ
HealthcareMedical - Specialties
$11.99
$0.02(0.17%)
U.S. Market opens in 11h 21m

Mobia Medical, Inc. Common Stock Fundamental Analysis

Mobia Medical, Inc. Common Stock (MOBI) shows moderate financial fundamentals with a PE ratio of -8.55, profit margin of -1.45%, and ROE of 30.84%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE30.84%
PEG Ratio-0.09
Current Ratio4.54

Areas of Concern

Operating Margin-1.45%
We analyze MOBI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -75.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-75.5/100

We analyze MOBI's fundamental strength across five key dimensions:

Efficiency Score

Weak

MOBI struggles to generate sufficient returns from assets.

ROA > 10%
-96.57%

Valuation Score

Excellent

MOBI trades at attractive valuation levels.

PE < 25
-8.55
PEG Ratio < 2
-0.09

Growth Score

Weak

MOBI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

MOBI maintains a strong and stable balance sheet.

Debt/Equity < 1
-0.06
Current Ratio > 1
4.54

Profitability Score

Weak

MOBI struggles to sustain strong margins.

ROE > 15%
30.84%
Net Margin ≥ 15%
-1.45%
Positive Free Cash Flow
No

Key Financial Metrics

Is MOBI Expensive or Cheap?

P/E Ratio

MOBI trades at -8.55 times earnings. This suggests potential undervaluation.

-8.55

PEG Ratio

When adjusting for growth, MOBI's PEG of -0.09 indicates potential undervaluation.

-0.09

Price to Book

The market values Mobia Medical, Inc. Common Stock at -2.65 times its book value. This may indicate undervaluation.

-2.65

EV/EBITDA

Enterprise value stands at -9.22 times EBITDA. This is generally considered low.

-9.22

How Well Does MOBI Make Money?

Net Profit Margin

For every $100 in sales, Mobia Medical, Inc. Common Stock keeps $-1.45 as profit after all expenses.

-1.45%

Operating Margin

Core operations generate -1.45 in profit for every $100 in revenue, before interest and taxes.

-1.45%

ROE

Management delivers $30.84 in profit for every $100 of shareholder equity.

30.84%

ROA

Mobia Medical, Inc. Common Stock generates $-96.57 in profit for every $100 in assets, demonstrating efficient asset deployment.

-96.57%

Following the Money - Real Cash Generation

Operating Cash Flow

Mobia Medical, Inc. Common Stock generates limited operating cash flow of $-45.92M, signaling weaker underlying cash strength.

$-45.92M

Free Cash Flow

Mobia Medical, Inc. Common Stock generates weak or negative free cash flow of $-46.29M, restricting financial flexibility.

$-46.29M

FCF Per Share

Each share generates $-1.39 in free cash annually.

$-1.39

FCF Yield

MOBI converts -11.52% of its market value into free cash.

-11.52%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.55

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.65

vs 25 benchmark

P/S Ratio

Price to sales ratio

12.51

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.54

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.31

vs 25 benchmark

ROA

Return on assets percentage

-0.97

vs 25 benchmark

ROCE

Return on capital employed

-1.22

vs 25 benchmark

How MOBI Stacks Against Its Sector Peers

MetricMOBI ValueSector AveragePerformance
P/E Ratio-8.5529.43 Better (Cheaper)
ROE30.84%426.00% Weak
Net Margin-145.12%-11473.00% (disorted) Weak
Debt/Equity-0.060.79 Strong (Low Leverage)
Current Ratio4.545.14 Strong Liquidity
ROA-96.57%-17.00% (disorted) Weak

MOBI outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Mobia Medical, Inc. Common Stock's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ